Fred Hutchinson Cancer Research Center

Latest stories

16h
Medical News Today
Could mimicking infants' immune response produce a faster-acting HIV vaccine?may lead to faster-acting, effective protection against the virus. In the jour
Could mimicking infants' immune response produce a faster-acting HIV vaccine?
Medical News Today / Posted 16 hours ago
may lead to faster-acting, effective protection against the virus. In the journal Cell, researchers led by a team from the Fred Hutchinson Cancer Research Center, Seattle, WA, describe how broadly neutralizing antibodies to HIV can arise in infants... Read more
6d
CBS News
Study linking education, brain tumors raises questionsgood for brain health. Neuroscientist Dr. Eric Holland, director of the Nancy
Study linking education, brain tumors raises questions
CBS News / Posted 6 days ago
good for brain health. Neuroscientist Dr. Eric Holland, director of the Nancy and Buster Alvord Brain Tumor Center at the Fred Hutchinson Cancer Research Center, told CBS News, "Alzheimer's and dementia are almost the opposite side of the spectrum... Read more
28 related stories
6d
The Seattle Times
‘We are never going to be finished’: Filmmaker Wes Hurley on gay rights, HIV and moreSeattle. It’s been picked up by a small network in Europe and another in Canada
‘We are never going to be finished’: Filmmaker Wes Hurley on gay rights, HIV and more
The Seattle Times / Posted 6 days ago
Seattle. It’s been picked up by a small network in Europe and another in Canada. But it also caught the attention of the Fred Hutchinson Cancer Research Center, which in April hired Hurley to produce commercials to connect with the gay community... Read more
7d
The Oklahoman
Mind Your Own Business: Others are beating the cancer that took my best friendresearch during Martha’s illness that the state of Washington was a leader in t
Mind Your Own Business: Others are beating the cancer that took my best friend
The Oklahoman / Posted 7 days ago
research during Martha’s illness that the state of Washington was a leader in the treatment. Selby confirmed that Seattle’s Fred Hutchinson Cancer Research Center had consistently better than expected outcomes, while others had lower outcomes and OU... Read more
10d
Bel Marra Health
Inflammatory bowel disease related colon cancer risk lowered with vitamin D: Studya detailed analysis of the effects of vitamin D on bowel inflammation. The lea
Inflammatory bowel disease related colon cancer risk lowered with vitamin D: Study
Bel Marra Health / Posted 10 days ago
a detailed analysis of the effects of vitamin D on bowel inflammation. The lead author of the study Dr. Stacy Meeker from Fred Hutchinson Cancer Research Center believes that by limiting inflammation, which drives tumor formation, vitamin D could... Read more
12d
News-Medical-Net
Interdisciplinary approach to improve cancer treatmentsthrough treatment Ross Levine, Memorial Sloan Kettering Cancer Center; Daniel
Interdisciplinary approach to improve cancer treatments
News-Medical-Net / Posted 12 days ago
through treatment Ross Levine, Memorial Sloan Kettering Cancer Center; Daniel Fisher, Stanford University; Harlan Robins, Fred Hutchinson Cancer Research Center; Jeffrey Engelman, Massachusetts General Hospital; Steven Altschuler, University of... Read more
14d
KING5 Seattle
Cancer patient turns researcher at Fred Hutch-- Dr. Heather Schuback is no stranger to cancer. She’s surrounded by it every
Cancer patient turns researcher at Fred Hutch
KING5 Seattle / Posted 14 days ago
-- Dr. Heather Schuback is no stranger to cancer. She’s surrounded by it every day through her research at Seattle’s Fred Hutchinson Cancer Research Center. Schuback says she feels at home here as if this is where she belongs. "This is very... Read more
14d
The Columbian
Seattle doctor’s research is saving kids with rare cancergame-changer,” said Dr. Scott Baker, director of the pediatric bone-marrow tran
Seattle doctor’s research is saving kids with rare cancer
The Columbian / Posted 14 days ago
game-changer,” said Dr. Scott Baker, director of the pediatric bone-marrow transplant program at Seattle Children’s and the Fred Hutchinson Cancer Research Center. He was not involved with the study. “It’s already sort of immediately taking... Read more
20d
WFMZ Eastern Pennsylvania and Western New Jersey
Cancer-detecting microscopeAs the inventor of tumor paint, a chemical that illuminates tumors during surge
Cancer-detecting microscope
WFMZ Eastern Pennsylvania and Western New Jersey / Posted 20 days ago
As the inventor of tumor paint, a chemical that illuminates tumors during surgery, Dr. Jim Olson, an oncologist at the Fred Hutchinson Cancer Research Center in Seattle, Washington, has been praised for his groundbreaking work, but now, he's excited... Read more
22d
The Seattle Times
‘Game-changer’: Seattle doc’s research is saving kids like Katie with rare cancergame-changer,” said Dr. Scott Baker, director of the pediatric bone-marrow tran
‘Game-changer’: Seattle doc’s research is saving kids like Katie with rare cancer
The Seattle Times / Posted 22 days ago
game-changer,” said Dr. Scott Baker, director of the pediatric bone-marrow transplant program at Seattle Children’s and the Fred Hutchinson Cancer Research Center. He was not involved with the study. “It’s already sort of immediately taking... Read more
23d
Business Wire
Juno Therapeutics’ Investigational CAR T Cell Product Candidate JCAR015 Shows High Response Rates in Adults with B-cell ALLJuno brings together innovative technologies from some of the world’s leading r
Juno Therapeutics’ Investigational CAR T Cell Product Candidate JCAR015 Shows High Response Rates in Adults with B-cell ALL
Business Wire / Posted 23 days ago
Juno brings together innovative technologies from some of the world’s leading research institutions, including the Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center, Seattle Children’s Research Institute, and... Read more
3 related stories
23d
Business Wire
Juno Therapeutics’ Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerabilitylymphoma (NHL), and chronic lymphocytic leukemia (CLL) will be presented today
Juno Therapeutics’ Defined Composition CD19 Product Candidates Demonstrate Encouraging Clinical Outcomes and Tolerability
Business Wire / Posted 23 days ago
lymphoma (NHL), and chronic lymphocytic leukemia (CLL) will be presented today by Cameron Turtle, MBBS, Ph.D., of the Fred Hutchinson Cancer Research Center. Key data include: In efficacy-evaluable ALL patients (N=34), complete remission was... Read more
3 related stories
25d
WTVM 9 Columbus
NEWS 9 MD: Cancer-detecting microscopethe inventor of tumor paint, a chemical that illuminates tumors during surgery,
NEWS 9 MD: Cancer-detecting microscope
WTVM 9 Columbus / Posted 25 days ago
the inventor of tumor paint, a chemical that illuminates tumors during surgery, Jim Olson, M.D., an oncologist at the Fred Hutchinson Cancer Research Center in Seattle, Washington, has been praised for his groundbreaking work. But now, he's... Read more
27d
Q13 FOX Seattle
22 ways to offer real support to a grieving parentto be there for a bereaved friend. That is true love incarnate. Linda Annette
22 ways to offer real support to a grieving parent
Q13 FOX Seattle / Posted 27 days ago
to be there for a bereaved friend. That is true love incarnate. Linda Annette Dahlstrom Anderson is a writer and editor at Fred Hutchinson Cancer Research Center and also a freelance writer for NBC News, TODAY and Mashable. She lives in Seattle... Read more
28d
News-Medical-Net
Oncologists combine two different types of immunotherapy to successfully treat metastatic melanomaOncologists at the Fred Hutchinson Cancer Research Center have successfully tre
Oncologists combine two different types of immunotherapy to successfully treat metastatic melanoma
News-Medical-Net / Posted 28 days ago
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach in a paper, "Combined... Read more
40 related stories
1m
The Globe and Mail
No easy answer as to whether talcum powder leads to ovarian cancerpowder is an interesting case, because it’s not something that’s necessary,” Dr
No easy answer as to whether talcum powder leads to ovarian cancer
The Globe and Mail / Posted a month ago
powder is an interesting case, because it’s not something that’s necessary,” Dr. Anne McTiernan, an epidemiologist with the Fred Hutchinson Cancer Research Center in Seattle, said. “If there’s any doubt, why should anyone use it?” As for Berg – the... Read more
2 related stories
1m
FOX News
New HIV vaccine trial aims to build on earlier modest successup trial to the only trial that has shown partial efficacy," said Dr. Larry Cor
New HIV vaccine trial aims to build on earlier modest success
FOX News / Posted a month ago
up trial to the only trial that has shown partial efficacy," said Dr. Larry Corey, president and director emeritus of Fred Hutchinson Cancer Research Center and principal investigator for the HIV Vaccine Trials Network in Seattle. The new... Read more
m
examiner.com
Miss USA 2016 contestants enjoy Vegas bikini weatherthe facts are almost always otherwise. Schmidt holds a bachelor’s degree in bio
Miss USA 2016 contestants enjoy Vegas bikini weather
examiner.com / Posted 1 months ago
the facts are almost always otherwise. Schmidt holds a bachelor’s degree in biology and is a pre-doctoral fellow at the Fred Hutchinson Cancer Research Center. Hardin majored in both anthropology and geography, with a minor in ethnic studies,... Read more
m
KING5 Seattle
Synthetic scorpion venom aims to help WA cancer patientsaccording to Tumor Paint’s maker, Blaze Bioscience. Dr. Jim Olson, a pediatric
Synthetic scorpion venom aims to help WA cancer patients
KING5 Seattle / Posted 1 months ago
according to Tumor Paint’s maker, Blaze Bioscience. Dr. Jim Olson, a pediatric neuro-oncologist and researcher at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital, developed the Tumor Paint technology. (©... Read more
m
News-Medical-Net
First large-scale proteogenomic study helps pinpoint genes that drive breast cancerProteomic Tumor Analysis Consortium (CPTAC), including Baylor College of Medici
First large-scale proteogenomic study helps pinpoint genes that drive breast cancer
News-Medical-Net / Posted 1 months ago
Proteomic Tumor Analysis Consortium (CPTAC), including Baylor College of Medicine, Broad Institute of MIT and Harvard, Fred Hutchinson Cancer Research Center, New York University Langone Medical Center and Washington University School of... Read more

People in this news